Eloxx Pharmaceuticals, Inc. (ELOX)

17.45 -0.10 (-0.57%) USD  |  OTCM  |  Sep 18, 16:00
17.69 +0.24 (+1.38%) After-Hours: 20:00
More

Eloxx Pharmaceuticals Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for ELOX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
September 18, 2026 --
September 11, 2026 --
August 20, 2026 --
July 20, 2026 --
February 12, 2024 --
November 02, 2023 --
Date Value
September 14, 2023 --
July 11, 2023 --
May 16, 2023 --
April 06, 2023 --
February 10, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Filana Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Breakthrough Chemistry, Inc. --
BioStem Technologies, Inc. Upgrade
Cardiac Biotech Solutions, Inc. --

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade